Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared on X:
“EV+pembrolizumab and GC+durvalumab reshape perioperative MIBC care.
But where does bladder preservation fit?
We need more data, shared decisions, and care guided by patient values.”
Other articles featuring Prof. Ürün on OncoDaily.